A case of ulceronecrotic Mucha-Habermann disease with pulmonary involvement.
Aydingöz
I E
IE
Kocaayan
N
N
Mansur
A T
AT
Pekcan
S
S
Arman
A
A
D000328:Adult; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001707:Biopsy, Needle; D004359:Drug Therapy, Combination; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D017514:Pityriasis Lichenoides / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D012867:Skin / Q000473:pathology*; D013203:Staphylococcal Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D013211:Staphylococcus aureus / Q000302:isolation & purification; D017334:Teicoplanin / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D017334:Teicoplanin; D000583:Amikacin; D008775:Methylprednisolone